Sean P. Nolan - 16 Aug 2023 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
Chief Executive Officer, Director
Signature
/s/ Kamran Alam, Attorney-in-Fact
Issuer symbol
TSHA
Transactions as of
16 Aug 2023
Transactions value $
$400,000
Form type
4
Date filed
16 Aug 2023, 20:52
Previous filing
18 May 2023
Next filing
18 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSHA Common Stock Purchase $400K +444K +40.73% $0.90 1.54M 16 Aug 2023 See Footnote F1
holding TSHA Common Stock 1.17K 16 Aug 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by Nolan Capital, LLC (the "LLC"). The Reporting Person is the President of the LLC and has shared voting and investment power with respect to the shares held by the LLC.